SEC Form 4 · accession 0001479290-18-000052
Revance Therapeutics, Inc. · RVNC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip J. Vickers
Director
Period of report
Mar 16, 2018
Accepted (ET)
Mar 16, 2018 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001479290
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2018 | P | 2,250 | $31.25 | A | 5,250 | D | |
| Common Stock | Mar 16, 2018 | P | 900 | $31.20 | A | 6,150 | D |
Table II — derivative securities
No Table II lines on this filing.